{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:23:12Z","timestamp":1747207392364,"version":"3.40.5"},"reference-count":187,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Many therapies have been developed against COVID-19 since it first appeared in December 2019. Antivirals, antimalarials, cephalosporins, colchicine, anticoagulants, and corticosteroids, among others, have been evaluated as protecting agents against antibacterial complications\ndue to their anti-inflammatory and immunomodulatory effects against thrombosis and cell death\ncaused by infection with SARS-CoV-2. Nevertheless, the overall balance in their application has\nnot been found to be satisfactory. On the other hand, developing and applying several vaccines\nagainst this virus have marked an important watershed in preventive and prophylactic medicine in\nthe new millennium. However, given the regular efficacy reported of some of them, the still scarce\naffordability, and the emergency of new strains for which no drug has been evaluated, the search\nfor new pharmacological therapy alternatives still represents an essential component in the clinical\nmanagement of COVID-19, and the rapid identification of drugs with potential antiviral and\/or\nimmunomodulatory properties is needed. In the present review, a potential therapeutic effect of\nmetformin and other antidiabetic therapies for the management of COVID-19 are proposed and\ndiscussed from the viewpoint of their in vitro and in vivo immunomodulatory effects. Given that\nacute inflammation is an important component of COVID-19, antidiabetic therapies could be promising alternatives in its management and reducing the disease's severity. In order to understand how\nmetformin and other antidiabetic therapies could work in the context of COVID-19, here we review\nthe possible mechanisms of action through a detailed description of cellular and molecular events.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871530322666220516115604","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T07:55:20Z","timestamp":1652774120000},"page":"255-272","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antidiabetic Drugs and their Potential Use in COVID-19: A Mechanistic\nApproach"],"prefix":"10.2174","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5428-393X","authenticated-orcid":true,"given":"Isaias","family":"Balderas-Renteria","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Pharmacology and Biological Models, School of Chemistry, Universidad Autonoma de Nuevo Leon,\nSan Nicolas de los Garza, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0967-2677","authenticated-orcid":true,"given":"Bryan Alejandro","family":"Espinosa-Rodriguez","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Pharmacology and Biological Models, School of Chemistry, Universidad Autonoma de Nuevo Leon,\nSan Nicolas de los Garza, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0203-2482","authenticated-orcid":true,"given":"Aissa Michelle","family":"Nieto-Moreno","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Pharmacology and Biological Models, School of Chemistry, Universidad Autonoma de Nuevo Leon,\nSan Nicolas de los Garza, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8563-9852","authenticated-orcid":true,"given":"Jose Luis","family":"Gonzalez Llerena","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Pharmacology and Biological Models, School of Chemistry, Universidad Autonoma de Nuevo Leon,\nSan Nicolas de los Garza, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6643-3384","authenticated-orcid":true,"given":"Tania Alejandra","family":"Rico-Torres","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Department, Hospital San Jose, TecSalud, Monterrey, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1890-4468","authenticated-orcid":true,"given":"Pilar","family":"Carranza-Rosales","sequence":"additional","affiliation":[{"name":"Laboratory of Cell Biology, Centro de Investigacion Biomedica del Noreste, Instituto Mexicano del Seguro Social, Monterrey,\nMexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Fernando","family":"Mendez-Lopez","sequence":"additional","affiliation":[{"name":"School of Nutrition and Public Health, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1056\/NEJMoa030781","volume":"348","author":"Ksiazek T.G.","year":"2003","unstructured":"Ksiazek T.G.; Erdman D.; Goldsmith C.S.; Zaki S.R.; Peret T.; Emery S.; Tong S.; Urbani C.; Comer J.A.; Lim W.; Rollin P.E.; Dowell S.F.; Ling A.E.; Humphrey C.D.; Shieh W.J.; Guarner J.; Paddock C.D.; Rota P.; Fields B.; DeRisi J.; Yang J.Y.; Cox N.; Hughes J.M.; LeDuc J.W.; Bellini W.J.; Anderson L.J.; A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003,348(20),1953-1966","journal-title":"N Engl J Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","volume":"5","year":"2020","unstructured":"The species severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol Coronaviridae Study Group of the International Committee on Taxonomy of Viruses2020,5(4),536-544","journal-title":"Nat Microbiol"},{"unstructured":"WHO. Coronavirus disease (COVID-19). Available from:  (Accessed on Aug 16, 2021).","key":"ref=3"},{"unstructured":"WHO. WHO Coronavirus (COVID-19). Available from:  (Accessed on Aug 16, 2021).","key":"ref=4"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.26355\/eurrev_202004_21038","volume":"24","author":"Meo S.A.","year":"2020","unstructured":"Meo S.A.; Klonoff D.C.; Akram J.; Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19. Eur Rev Med Pharmacol Sci 2020,24(8),4539-4547","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.jsps.2020.11.003","volume":"28","author":"Takla M.","year":"2020","unstructured":"Takla M.; Jeevaratnam K.; Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety. Saudi Pharm J 2020,28(12),1760-1776","journal-title":"Saudi Pharm J"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pathogens10020217","volume":"10","author":"Ho T.C.","year":"2021","unstructured":"Ho T.C.; Wang Y.H.; Chen Y.L.; Tsai W.C.; Lee C.H.; Chuang K.P.; Chen Y.A.; Yuan C.H.; Ho S.Y.; Yang M.H.; Tyan Y.C.; Chloroquine and hydroxychloroquine: Efficacy in the treatment of the COVID-19. Pathogens 2021,10(2),1-9","journal-title":"Pathogens"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics10070763","volume":"10","author":"Giacobbe D.R.","year":"2021","unstructured":"Giacobbe D.R.; Russo C.; Martini V.; Dettori S.; Briano F.; Mirabella M.; Portunato F.; Dentone C.; Mora S.; Giacomini M.; Berruti M.; Bassetti M.; Use of ceftaroline in hospitalized patients with and without COVID-19: A descriptive cross-sectional study. Antibiotics (Basel) 2021,10(7),1-10","journal-title":"Antibiotics (Basel)"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4046\/trd.2021.0075","volume":"84","author":"Mangkuliguna G.","year":"2021","unstructured":"Mangkuliguna G.; Glenardi; Natalia; Pramono, L.A. Efficacy and safety of azithromycin for the treatment of COVID-19: A systematic review and meta-analysis. Tuberc Respir Dis (Seoul) 2021,84(4),299-316","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S2213-2600(21)00222-8","volume":"9","author":"Tardif J.C.","year":"2021","unstructured":"Tardif J.C.; Bouabdallaoui N.; L\u2019Allier P.L.; Gaudet D.; Shah B.; Pillinger M.H.; Lopez-Sendon J.; da Luz P.; Verret L.; Audet S.; Dupuis J.; Denault A.; Pelletier M.; Tessier P.A.; Samson S.; Fortin D.; Tardif J.D.; Busseuil D.; Goulet E.; Lacoste C.; Dubois A.; Joshi A.Y.; Waters D.D.; Hsue P.; Lepor N.E.; Lesage F.; Sainturet N.; Roy-Clavel E.; Bassevitch Z.; Orfanos A.; Stamatescu G.; Gr&#xE9;goire J.C.; Busque L.; Lavall&#xE9;e C.; H&#xE9;tu P.O.; Paquette J.S.; Deftereos S.G.; Levesque S.; Cossette M.; Nozza A.; Chabot-Blanchet M.; Dub&#xE9; M.P.; Guertin M.C.; Boivin G.; Colchicine for community-treated patients with COVID-19 (COLCORONA): A phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial. Lancet Respir Med 2021,9(8),924-932","journal-title":"Lancet Respir Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s40264-020-00966-9","volume":"43","author":"Osborne V.","year":"2020","unstructured":"Osborne V.; Davies M.; Lane S.; Evans A.; Denyer J.; Dhanda S.; Roy D.; Shakir S.; Lopinavir-ritonavir in the treatment of COVID-19: A dynamic systematic benefit-risk assessment. Drug Saf 2020,43(8),809-821","journal-title":"Drug Saf"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(20)32013-4","volume":"396","author":"Horby P.W.","year":"2020","unstructured":"Horby P.W.; Mafham M.; Bell J.L.; Linsell L.; Staplin N.; Emberson J.; Palfreeman A.; Raw J.; Elmahi E.; Prudon B.; Green C.; Carley S.; Chadwick D.; Davies M.; Wise M.P.; Baillie J.K.; Chappell L.C.; Faust S.N.; Jaki T.; Jefferey K.; Lim W.S.; Montgomery A.; Rowan K.; Juszczak E.; Haynes R.; Landray M.J.; Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial. Lancet 2020,396(10259),1345-1352","journal-title":"Lancet"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1056\/NEJMoa2015301","volume":"383","author":"Goldman J.D.","year":"2020","unstructured":"Goldman J.D.; Lye D.C.B.; Hui D.S.; Marks K.M.; Bruno R.; Montejano R.; Spinner C.D.; Galli M.; Ahn M-Y.; Nahass R.G.; Chen Y.S.; SenGupta D.; Hyland R.H.; Osinusi A.O.; Cao H.; Blair C.; Wei X.; Gaggar A.; Brainard D.M.; Towner W.J.; Mu&#xF1;oz J.; Mullane K.M.; Marty F.M.; Tashima K.T.; Diaz G.; Subramanian A.; Remdesivir for 5 or 10 days in patients with severe Covid-19. N Engl J Med 2020,383(19),1827-1837","journal-title":"N Engl J Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"663","DOI":"10.7326\/M20-8148","volume":"174","author":"Kaka A.S.","year":"2021","unstructured":"Kaka A.S.; MacDonald R.; Greer N.; Vela K.; Duan-Porter W.; Obley A.; Wilt T.J.; Major update: Remdesivir for adults with COVID-19: A living systematic review and meta-analysis for the American College of Physicians Practice Points. Ann Intern Med 2021,174(5),663-672","journal-title":"Ann Intern Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1055\/s-0040-1720978","volume":"120","author":"Billett H.H.","year":"2020","unstructured":"Billett H.H.; Reyes-Gil M.; Szymanski J.; Ikemura K.; Stahl L.R.; Lo Y.; Rahman S.; Gonzalez-Lugo J.D.; Kushnir M.; Barouqa M.; Golestaneh L.; Bellin E.; Anticoagulation in COVID-19: Effect of enoxaparin, heparin, and apixaban on mortality. Thromb Haemost 2020,120(12),1691-1699","journal-title":"Thromb Haemost"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1055\/a-1347-6070","volume":"121","author":"Di Castelnuovo A.","year":"2021","unstructured":"Di Castelnuovo A.; Costanzo S.; Antinori A.; Berselli N.; Blandi L.; Bonaccio M.; Cauda R.; Guaraldi G.; Menicanti L.; Mennuni M.; Parruti G.; Patti G.; Santilli F.; Signorelli C.; Vergori A.; Abete P.; Ageno W.; Agodi A.; Agostoni P.; Aiello L.; Al Moghazi S.; Arboretti R.; Astuto M.; Aucella F.; Barbieri G.; Bartoloni A.; Bonfanti P.; Cacciatore F.; Caiano L.; Carrozzi L.; Cascio A.; Ciccullo A.; Cingolani A.; Cipollone F.; Colomba C.; Colombo C.; Crosta F.; Danzi G.B.; D\u2019Ardes D.; de Gaetano Donati K.; Di Gennaro F.; Di Tano G.; D\u2019Offizi G.; Fantoni M.; Fusco F.M.; Gentile I.; Gianfagna F.; Grandone E.; Graziani E.; Grisafi L.; Guarnieri G.; Larizza G.; Leone A.; Maccagni G.; Madaro F.; Maitan S.; Mancarella S.; Mapelli M.; Maragna R.; Marcucci R.; Maresca G.; Marongiu S.; Marotta C.; Marra L.; Mastroianni F.; Mazzitelli M.; Mengozzi A.; Menichetti F.; Meschiari M.; Milic J.; Minutolo F.; Molena B.; Montineri A.; Mussini C.; Musso M.; Niola D.; Odone A.; Olivieri M.; Palimodde A.; Parisi R.; Pasi E.; Pesavento R.; Petri F.; Pinchera B.; Poletti V.; Ravaglia C.; Rognoni A.; Rossato M.; Rossi M.; Sangiovanni V.; Sanrocco C.; Scorzolini L.; Sgariglia R.; Simeone P.G.; Taddei E.; Torti C.; Vettor R.; Vianello A.; Vinceti M.; Virano A.; Vocciante L.; De Caterina R.; Iacoviello L.; Heparin in COVID-19 patients is associated with reduced in-hospital mortality: The multicenter Italian Corist study. Thromb Haemost 2021,121(8),1054-1065","journal-title":"Thromb Haemost"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s12879-021-06119-2","volume":"21","author":"Hasan M.J.","year":"2021","unstructured":"Hasan M.J.; Rabbani R.; Anam A.M.; Huq S.M.R.; Polash M.M.I.; Nessa S.S.T.; Bachar S.C.; Impact of high dose of baricitinib in severe COVID-19 pneumonia: A prospective cohort study in Bangladesh. BMC Infect Dis 2021,21(1),427","journal-title":"BMC Infect Dis"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa2031994","volume":"384","author":"Kalil A.C.","year":"2021","unstructured":"Kalil A.C.; Patterson T.F.; Mehta A.K.; Tomashek K.M.; Wolfe C.R.; Ghazaryan V.; Marconi V.C.; Ruiz-Palacios G.M.; Hsieh L.; Kline S.; Tapson V.; Iovine N.M.; Jain M.K.; Sweeney D.A.; El Sahly H.M.; Branche A.R.; Regalado Pineda J.; Lye D.C.; Sandkovsky U.; Luetkemeyer A.F.; Cohen S.H.; Finberg R.W.; Jackson P.E.H.; Taiwo B.; Paules C.I.; Arguinchona H.; Erdmann N.; Ahuja N.; Frank M.; Oh M.D.; Kim E.S.; Tan S.Y.; Mularski R.A.; Nielsen H.; Ponce P.O.; Taylor B.S.; Larson L.; Rouphael N.G.; Saklawi Y.; Cantos V.D.; Ko E.R.; Engemann J.J.; Amin A.N.; Watanabe M.; Billings J.; Elie M.C.; Davey R.T.; Burgess T.H.; Ferreira J.; Green M.; Makowski M.; Cardoso A.; de Bono S.; Bonnett T.; Proschan M.; Deye G.A.; Dempsey W.; Nayak S.U.; Dodd L.E.; Beigel J.H.; Baricitinib plus remdesivir for hospitalized adults with Covid-19. N Engl J Med 2021,384(9),795-807","journal-title":"N Engl J Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s11684-020-0824-3","volume":"15","author":"Wang D.","year":"2021","unstructured":"Wang D.; Fu B.; Peng Z.; Yang D.; Han M.; Li M.; Yang Y.; Yang T.; Sun L.; Li W.; Shi W.; Yao X.; Ma Y.; Xu F.; Wang X.; Chen J.; Xia D.; Sun Y.; Dong L.; Wang J.; Zhu X.; Zhang M.; Zhou Y.; Pan A.; Hu X.; Mei X.; Wei H.; Xu X.; Tocilizumab in patients with moderate or severe COVID-19: A randomized, controlled, open-label, multicenter trial. Front Med 2021,15(3),486-494","journal-title":"Front Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","volume":"384","author":"Rosas I.O.","year":"2021","unstructured":"Rosas I.O.; Br&#xE4;u N.; Waters M.; Go R.C.; Hunter B.D.; Bhagani S.; Skiest D.; Aziz M.S.; Cooper N.; Douglas I.S.; Savic S.; Youngstein T.; Del Sorbo L.; Cubillo Gracian A.; De La Zerda D.J.; Ustianowski A.; Bao M.; Dimonaco S.; Graham E.; Matharu B.; Spotswood H.; Tsai L.; Malhotra A.; Tocilizumab in hospitalized patients with severe COVID-19 pneumonia. N Engl J Med 2021,384(16),1503-1516","journal-title":"N Engl J Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s40744-016-0037-z","volume":"3","author":"Monemi S.","year":"2016","unstructured":"Monemi S.; Berber E.; Sarsour K.; Wang J.; Lampl K.; Bharucha K.; Pethoe-Schramm A.; Incidence of gastrointestinal perforations in patients with rheumatoid arthritis treated with tocilizumab from clinical trial, postmarketing, and real-world data sources. Rheumatol Ther 2016,3(2),337-352","journal-title":"Rheumatol Ther"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"10727","DOI":"10.1038\/s41598-021-90246-y","volume":"11","author":"Ikeda S.","year":"2021","unstructured":"Ikeda S.; Misumi T.; Izumi S.; Sakamoto K.; Nishimura N.; Ro S.; Fukunaga K.; Okamori S.; Tachikawa N.; Miyata N.; Shinkai M.; Shinoda M.; Miyazaki Y.; Iijima Y.; Izumo T.; Inomata M.; Okamoto M.; Yamaguchi T.; Iwabuchi K.; Masuda M.; Takoi H.; Oyamada Y.; Fujitani S.; Mineshita M.; Ishii H.; Nakagawa A.; Yamaguchi N.; Hibino M.; Tsushima K.; Nagai T.; Ishikawa S.; Ishikawa N.; Kondoh Y.; Yamazaki Y.; Gocho K.; Nishizawa T.; Tsuzuku A.; Yagi K.; Shindo Y.; Takeda Y.; Yamanaka T.; Ogura T.; Corticosteroids for hospitalized patients with mild to critically-ill COVID-19: A multicenter, retrospective, propensity score-matched study. Sci Rep 2021,11(1),10727","journal-title":"Sci Rep"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"Horby P.","year":"2021","unstructured":"Horby P.; Lim W.S.; Emberson J.R.; Mafham M.; Bell J.L.; Linsell L.; Staplin N.; Brightling C.; Ustianowski A.; Elmahi E.; Prudon B.; Green C.; Felton T.; Chadwick D.; Rege K.; Fegan C.; Chappell L.C.; Faust S.N.; Jaki T.; Jeffery K.; Montgomery A.; Rowan K.; Juszczak E.; Baillie J.K.; Haynes R.; Landray M.J.; Dexamethasone in hospitalized patients with COVID-19. N Engl J Med 2021,384(8),693-704","journal-title":"N Engl J Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1093\/cid\/ciab079","volume":"73","author":"Moghadas S.M.","year":"2021","unstructured":"Moghadas S.M.; Vilches T.N.; Zhang K.; Wells C.R.; Shoukat A.; Singer B.H.; Meyers L.A.; Neuzil K.M.; Langley J.M.; Fitzpatrick M.C.; Galvani A.P.; The impact of vaccination on coronavirus disease 2019 (COVID-19) outbreaks in the United States. Clin Infect Dis 2021,73(12),2257-2264","journal-title":"Clin Infect Dis"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1088-1093","DOI":"10.15585\/mmwr.mm7032e3","volume":"70","author":"Moline H. L.","year":"2021","unstructured":"Moline H. L.; Whitaker M.; Deng L.; Rhodes J. C.; Milucky J.; Pham H.; Effectiveness of COVID-19 vaccines in preventing hospitalization among adults aged \u2265 65 years - COVID-NET , 13 States , February - April 2021. 2021,70(32),1088-1093"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/tropicalmed6030129","volume":"6","author":"Alencar C.H.","year":"2021","unstructured":"Alencar C.H.; Cavalcanti L.P.G.; Almeida M.M.; Barbosa P.P.L.; Cavalcante K.K.S.; Melo D.N.; de Brito Alves B.C.F.; Heukelbach J.; High effectiveness of SARS-CoV-2 vaccines in reducing COVID-19-related deaths in over 75-year-olds, Cear&#xE1; State, Brazil. Trop Med Infect Dis 2021,6(3),129","journal-title":"Trop Med Infect Dis"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(21)00306-8","volume":"397","author":"Wouters O.J.","year":"2021","unstructured":"Wouters O.J.; Shadlen K.C.; Salcher-Konrad M.; Pollard A.J.; Larson H.J.; Teerawattananon Y.; Jit M.; Challenges in ensuring global access to COVID-19 vaccines: Production, affordability, allocation, and deployment. Lancet 2021,397(10278),1023-1034","journal-title":"Lancet"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/14760584.2021.1903879","volume":"20","author":"Bian L.","year":"2021","unstructured":"Bian L.; Gao F.; Zhang J.; He Q.; Mao Q.; Xu M.; Liang Z.; Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies. Expert Rev Vaccines 2021,20(4),365-373","journal-title":"Expert Rev Vaccines"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/pdi.606","volume":"21","author":"Bailey C.J.","year":"2004","unstructured":"Bailey C.J.; Day C.; Metformin: Its botanical background. Pract Diabetes Int 2004,21(3),115-117","journal-title":"Pract Diabetes Int"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/bmj.2.6135.464","volume":"2","author":"Bergman U.","year":"1978","unstructured":"Bergman U.; Boman G.; Wiholm B.E.; Epidemiology of adverse drug reactions to phenformin and metformin. BMJ 1978,2(6135),464-466","journal-title":"BMJ"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1475-2891-13-17","volume":"13","author":"Grygiel-G&#xF3;rniak B.","year":"2014","unstructured":"Grygiel-G&#xF3;rniak B.; Peroxisome proliferator-activated receptors and their ligands: Nutritional and clinical implications--a review. Nutr J 2014,13(1),17","journal-title":"Nutr J"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ijid.2020.05.055","volume":"96","author":"Zeng F.","year":"2020","unstructured":"Zeng F.; Huang Y.; Guo Y.; Yin M.; Chen X.; Xiao L.; Deng G.; Association of inflammatory markers with the severity of COVID-19: A meta-analysis. Int J Infect Dis 2020,96,467-474","journal-title":"Int J Infect Dis"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.arcmed.2021.08.002","volume":"53","author":"Han T.","year":"2022","unstructured":"Han T.; Ma S.; Sun C.; Zhang H.; Qu G.; Chen Y.; Cheng C.; The association between anti-diabetic agents and clinical outcomes of COVID-19 in patients with diabetes: A systematic review and meta-analysis. Arch Med Res 2022,53(2),186-195","journal-title":"Arch Med Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"108977","DOI":"10.1016\/j.diabres.2021.108977","volume":"178","author":"Yang W.","year":"2021","unstructured":"Yang W.; Sun X.; Zhang J.; Zhang K.; The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus. Clin Pract 2021,178(108977),108977","journal-title":"Clin Pract"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.3390\/jcm10163507","volume":"10","author":"Poly T.N.","year":"2021","unstructured":"Poly T.N.; Islam M.M.; Li Y.J.; Lin M.C.; Hsu M.H.; Wang Y.C.; Metformin use is associated with decreased mortality in COVID-19 patients with diabetes: Evidence from retrospective studies and biological mechanism. J Clin Med 2021,10(16),3507","journal-title":"J Clin Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1021\/acs.molpharmaceut.0c00608","volume":"18","author":"Salian V.S.","year":"2021","unstructured":"Salian V.S.; Wright J.A.; Vedell P.T.; Nair S.; Li C.; Kandimalla M.; Tang X.; Porquera C.E.M.; Kalari K.R.; Kandimalla K.K.; COVID-19 transmission, current treatment, and future therapeutic strategies. Mol Pharm 2021,18(3),754-771","journal-title":"Mol Pharm"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1056\/NEJMc2004973","volume":"382","author":"van Doremalen N.","year":"2020","unstructured":"van Doremalen N.; Bushmaker T.; Morris D.H.; Holbrook M.G.; Gamble A.; Williamson B.N.; Tamin A.; Harcourt J.L.; Thornburg N.J.; Gerber S.I.; Lloyd-Smith J.O.; de Wit E.; Munster V.J.; Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020,382(16),1564-1567","journal-title":"N Engl J Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.1128\/JVI.78.9.4552-4560.2004","volume":"78","author":"Babcock G.J.","year":"2004","unstructured":"Babcock G.J.; Esshaki D.J.; Thomas W.D.; Ambrosino D.M.; Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor. J Virol 2004,78(9),4552-4560","journal-title":"J Virol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"Hoffmann M.","year":"2020","unstructured":"Hoffmann M.; Kleine-Weber H.; Schroeder S.; Kr&#xFC;ger N.; Herrler T.; Erichsen S.; Schiergens T.S.; Herrler G.; Wu N.H.; Nitsche A.; M&#xFC;ller M.A.; Drosten C.; P&#xF6;hlmann S.; SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020,181(2),271-280.e8","journal-title":"Cell"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","volume":"9","author":"Chan J.F.W.","year":"2020","unstructured":"Chan J.F.W.; Kok K.H.; Zhu Z.; Chu H.; To K.K.W.; Yuan S.; Yuen K.Y.; Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 2020,9(1),221-236","journal-title":"Emerg Microbes Infect"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","volume":"181","author":"Wang Q.","year":"2020","unstructured":"Wang Q.; Zhang Y.; Wu L.; Niu S.; Song C.; Zhang Z.; Lu G.; Qiao C.; Hu Y.; Yuen K.Y.; Wang Q.; Zhou H.; Yan J.; Qi J.; Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell 2020,181(4),894-904.e9","journal-title":"Cell"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","volume":"5","author":"Letko M.","year":"2020","unstructured":"Letko M.; Marzi A.; Munster V.; Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol 2020,5(4),562-569","journal-title":"Nat Microbiol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.3390\/cells10071814","volume":"10","author":"Karthika T.","year":"2021","unstructured":"Karthika T.; Joseph J.; Das V.R.A.; Nair N.; Charulekha P.; Roji M.D.; Raj V.S.; SARS-CoV-2 cellular entry is independent of the ACE2 cytoplasmic domain signaling. Cells 2021,10(7),1814","journal-title":"Cells"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41422-020-00460-y","volume":"31","author":"Wang S.","year":"2021","unstructured":"Wang S.; Qiu Z.; Hou Y.; Deng X.; Xu W.; Zheng T.; Wu P.; Xie S.; Bian W.; Zhang C.; Sun Z.; Liu K.; Shan C.; Lin A.; Jiang S.; Xie Y.; Zhou Q.; Lu L.; Huang J.; Li X.; AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells. Cell Res 2021,31(2),126-140","journal-title":"Cell Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"Hamming I.","year":"2004","unstructured":"Hamming I.; Timens W.; Bulthuis M.L.C.; Lely A.T.; Navis G.; van Goor H.; Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004,203(2),631-637","journal-title":"J Pathol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"594495","DOI":"10.3389\/fmed.2020.594495","volume":"7","author":"Salamanna F.","year":"2020","unstructured":"Salamanna F.; Maglio M.; Landini M.P.; Fini M.; Body localization of ACE-2: On the trail of the keyhole of SARS-CoV-2. Front Med (Lausanne) 2020,7,594495","journal-title":"Front Med (Lausanne)"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","volume":"14","author":"Zou X.","year":"2020","unstructured":"Zou X.; Chen K.; Zou J.; Han P.; Hao J.; Han Z.; Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med 2020,14(2),185-192","journal-title":"Front Med"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"6949902","DOI":"10.1155\/2021\/6949902","volume":"2021","author":"Liu Y.","year":"2021","unstructured":"Liu Y.; Wu Q.; Wan D.; He H.; Lin H.; Wang K.; Que G.; Wang Y.; Chen Y.; Tang X.; Wu L.; Yang X.; Expression and possible significance of ACE2 in the human liver, esophagus, stomach, and colon. Evid Based Complement Alternat Med 2021,2021,6949902","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/bph.12159","volume":"169","author":"Sim&#xF5;es e Silva A.C.","year":"2013","unstructured":"Sim&#xF5;es e Silva A.C.; Silveira K.D.; Ferreira A.J.; Teixeira M.M.; ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis. Br J Pharmacol 2013,169(3),477-492","journal-title":"Br J Pharmacol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"21-38","DOI":"10.1016\/j.phrs.2017.06.005","volume":"125","author":"Li X.C.","year":"2017","unstructured":"Li X.C.; Zhang J.; Zhuo J.L.; The vasoprotective axes of the reninangiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases. Pharmacol. Res. 2017,125(Pt A),21-38"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"4122","DOI":"10.1128\/JVI.02232-10","volume":"85","author":"Glowacka I.","year":"2011","unstructured":"Glowacka I.; Bertram S.; M&#xFC;ller M.A.; Allen P.; Soilleux E.; Pfefferle S.; Steffen I.; Tsegaye T.S.; He Y.; Gnirss K.; Niemeyer D.; Schneider H.; Drosten C.; P&#xF6;hlmann S.; Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol 2011,85(9),4122-4134","journal-title":"J Virol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","volume":"41","author":"Huang Y.","year":"2020","unstructured":"Huang Y.; Yang C.; Xu X.F.; Xu W.; Liu S.W.; Structural and functional properties of SARS-CoV-2 spike protein: Potential antivirus drug development for COVID-19. Acta Pharmacol Sin 2020,41(9),1141-1149","journal-title":"Acta Pharmacol Sin"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","volume":"11","author":"Ou X.","year":"2020","unstructured":"Ou X.; Liu Y.; Lei X.; Li P.; Mi D.; Ren L.; Guo L.; Guo R.; Chen T.; Hu J.; Xiang Z.; Mu Z.; Chen X.; Chen J.; Hu K.; Jin Q.; Wang J.; Qian Z.; Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun 2020,11(1),1620","journal-title":"Nat Commun"},{"key":"ref=54","doi-asserted-by":"publisher","DOI":"10.1101\/2020.08.26.268854","author":"Johnson B.A.","year":"2020","unstructured":"Johnson B.A.; Xie X.; Kalveram B.; Lokugamage K.G.; Muruato A.; Zou J.; Zhang X.; Juelich T.; Smith J.K.; Zhang L.; Furin cleavage site is key to SARS-CoV-2 pathogenesis. bioRxiv 2020","journal-title":"bioRxiv"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s41065-020-00168-4","volume":"158","author":"Yang J.","year":"2021","unstructured":"Yang J.; Chen T.; Zhou Y.; Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes. Hereditas 2021,158(1),4","journal-title":"Hereditas"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"Wang D.","year":"2020","unstructured":"Wang D.; Hu B.; Hu C.; Zhu F.; Liu X.; Zhang J.; Wang B.; Xiang H.; Cheng Z.; Xiong Y.; Zhao Y.; Li Y.; Wang X.; Peng Z.; Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020,323(11),1061-1069","journal-title":"JAMA"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"e21824","DOI":"10.1097\/MD.0000000000021824","volume":"99","author":"Zhou J.","year":"2020","unstructured":"Zhou J.; Sun J.; Cao Z.; Wang W.; Huang K.; Zheng F.; Xie Y.; Jiang D.; Zhou Z.; Epidemiological and clinical features of 201 COVID-19 patients in Changsha city, Hunan, China. Medicine (Baltimore) 2020,99(34),e21824","journal-title":"Medicine (Baltimore)"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jiph.2020.07.002","volume":"13","author":"Yu C.","year":"2020","unstructured":"Yu C.; Lei Q.; Li W.; Wang X.; Li W.; Liu W.; Epidemiological and clinical characteristics of 1663 hospitalized patients infected with COVID-19 in Wuhan, China: A single-center experience. J Infect Public Health 2020,13(9),1202-1209","journal-title":"J Infect Public Health"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"104821","DOI":"10.1016\/j.phrs.2020.104821","volume":"157","author":"Zheng Y.","year":"2020","unstructured":"Zheng Y.; Xiong C.; Liu Y.; Qian X.; Tang Y.; Liu L.; Leung E.L.H.; Wang M.; Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020. Pharmacol Res 2020,157,104821","journal-title":"Pharmacol Res"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"577","DOI":"10.7326\/M20-0504","volume":"172","author":"Lauer S.A.","year":"2020","unstructured":"Lauer S.A.; Grantz K.H.; Bi Q.; Jones F.K.; Zheng Q.; Meredith H.R.; Azman A.S.; Reich N.G.; Lessler J.; The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application. Ann Intern Med 2020,172(9),577-582","journal-title":"Ann Intern Med"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.15167\/2421-4248\/jpmh2021.62.1.1680","volume":"62","author":"Zizza A.","year":"2021","unstructured":"Zizza A.; Recchia V.; Aloisi A.; Guido M.; Clinical features of COVID-19 and SARS epidemics. A literature review. J Prev Med Hyg 2021,62(1),E13-E24","journal-title":"J Prev Med Hyg"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","volume":"19","author":"Mcgonagle D.","year":"2020","unstructured":"Mcgonagle D.; Sharif K.; Regan A.O.; Bridgewood C.; The role of cytokines including IL-6 in COVID-19 induced pneumonia and MAS-like disease. Autoimmun Rev 2020,19(6),102537","journal-title":"Autoimmun Rev"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","volume":"80","author":"Ye Q.","year":"2020","unstructured":"Ye Q.; Wang B.; Mao J.; The pathogenesis and treatment of the \u2018Cytokine Storm\u2019 in COVID-19. J Infect 2020,80(6),607-613","journal-title":"J Infect"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"316","DOI":"10.7150\/thno.49713","volume":"11","author":"Kim J.S.","year":"2021","unstructured":"Kim J.S.; Lee J.Y.; Yang J.W.; Lee K.H.; Effenberger M.; Szpirt W.; Kronbichler A.; Shin J.I.; Immunopathogenesis and treatment of cytokine storm in COVID-19. Theranostics 2021,11(1),316-329","journal-title":"Theranostics"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1093\/cid\/ciaa410","volume":"71","author":"Chu H.","year":"2020","unstructured":"Chu H.; Chan J.F-W.; Wang Y.; Yuen T.T-T.; Chai Y.; Hou Y.; Shuai H.; Yang D.; Hu B.; Huang X.; Zhang X.; Cai J.P.; Zhou J.; Yuan S.; Kok K.H.; To K.K.; Chan I.H.; Zhang A.J.; Sit K.Y.; Au W.K.; Yuen K.Y.; Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: An ex vivo study with implications for the pathogenesis of COVID-19. Clin Infect Dis 2020,71(6),1400-1409","journal-title":"Clin Infect Dis"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1080\/22221751.2020.1780953","volume":"9","author":"Yuen C.K.","year":"2020","unstructured":"Yuen C.K.; Lam J.Y.; Wong W.M.; Mak L.F.; Wang X.; Chu H.; Cai J.P.; Jin D.Y.; To K.K.; Chan J.F.; Yuen K.Y.; Kok K.H.; SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists. Emerg Microbes Infect 2020,9(1),1418-1428","journal-title":"Emerg Microbes Infect"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/infdis\/jiaa356","volume":"222","author":"Yang D.","year":"2020","unstructured":"Yang D.; Chu H.; Hou Y.; Chai Y.; Shuai H.; Lee A.C.Y.; Zhang X.; Wang Y.; Hu B.; Huang X.; Yuen T.T.; Cai J.P.; Zhou J.; Yuan S.; Zhang A.J.; Chan J.F.; Yuen K.Y.; Attenuated interferon and proinflammatory response in SARS-CoV-2-infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation. J Infect Dis 2020,222(5),734-745","journal-title":"J Infect Dis"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","volume":"39","author":"Channappanavar R.","year":"2017","unstructured":"Channappanavar R.; Perlman S.; Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 2017,39(5),529-539","journal-title":"Semin Immunopathol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"Merad M.","year":"2020","unstructured":"Merad M.; Martin J.C.; Pathological inflammation in patients with COVID-19: A key role for monocytes and macrophages. Nat Rev Immunol 2020,20(6),355-362","journal-title":"Nat Rev Immunol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.virol.2007.04.009","volume":"365","author":"Zhang X.","year":"2007","unstructured":"Zhang X.; Wu K.; Wang D.; Yue X.; Song D.; Zhu Y.; Wu J.; Nucleocapsid protein of SARS-CoV activates interleukin-6 expression through cellular transcription factor NF-kappaB. Virology 2007,365(2),324-335","journal-title":"Virology"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/vaccines9010054","volume":"9","author":"Karwaciak I.","year":"2021","unstructured":"Karwaciak I.; Sa\u0142kowska, A.; Kara&#x15B; K.; Dastych, J.; Ratajewski, M. Nucleocapsid and spike proteins of the coronavirus SARS-CoV-2 Induce IL6 in monocytes and macrophages-potential implications for cytokine storm syndrome. Vaccines (Basel) 2021,9(1),54","journal-title":"Vaccines (Basel)"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1186\/s13054-020-03328-0","volume":"24","author":"Blot M.","year":"2020","unstructured":"Blot M.; Jacquier M.; Aho Glele L.S.; Beltramo G.; Nguyen M.; Bonniaud P.; Prin S.; Andreu P.; Bouhemad B.; Bour J.B.; Binquet C.; Piroth L.; Pais de Barros J.P.; Masson D.; Quenot J.P.; Charles P.E.; Aptel F.; Dargent A.; Georges M.; Labruy&#xE8;re M.; Lagrost L.; Large A.; Monier S.; Roudaut J-B.; Thomas C.; CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS. Crit Care 2020,24(1),632","journal-title":"Crit Care"},{"key":"ref=73","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.27.20045427","author":"Feng Z.","year":"2020","unstructured":"Feng Z.; Diao B.; Wang R.; Wang G.; Wang C.; Tan Y.; Liu L.; Wang C.; Liu Y.; Liu Y.; The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Directly decimates human spleens and lymph nodes. medRxiv 2020","journal-title":"medRxiv"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"Blanco-Melo D.","year":"2020","unstructured":"Blanco-Melo D.; Nilsson-Payant B.E.; Liu W-C.; Uhl S.; Hoagland D.; M&#xF8;ller R.; Jordan T.X.; Oishi K.; Panis M.; Sachs D.; Wang T.T.; Schwartz R.E.; Lim J.K.; Albrecht R.A.; tenOever B.R.; Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 2020,181(5),1036-1045.e9","journal-title":"Cell"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.immuni.2020.07.026","volume":"53","author":"Zhou R.","year":"2020","unstructured":"Zhou R.; To K.K.W.; Wong Y.C.; Liu L.; Zhou B.; Li X.; Huang H.; Mo Y.; Luk T.Y.; Lau T.T.K.; Yeung P.; Chan W.M.; Wu A.K.; Lung K.C.; Tsang O.T.; Leung W.S.; Hung I.F.; Yuen K.Y.; Chen Z.; Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses. Immunity 2020,53(4),864-877.e5","journal-title":"Immunity"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","volume":"11","author":"Diao B.","year":"2020","unstructured":"Diao B.; Wang C.; Tan Y.; Chen X.; Liu Y.; Ning L.; Chen L.; Li M.; Liu Y.; Wang G.; Yuan Z.; Feng Z.; Zhang Y.; Wu Y.; Chen Y.; Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol 2020,11,827","journal-title":"Front Immunol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1016\/j.xphs.2017.04.078","volume":"106","author":"Liang X.","year":"2017","unstructured":"Liang X.; Giacomini K.M.; Transporters involved in metformin pharmacokinetics and treatment response. J Pharm Sci 2017,106(9),2245-2250","journal-title":"J Pharm Sci"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/bj3480607","volume":"348","author":"Owen M.R.","year":"2000","unstructured":"Owen M.R.; Doran E.; Halestrap A.P.; Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 2000,348(Pt 3),607-614","journal-title":"Biochem J"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.1210\/en.2012-1145","volume":"153","author":"Hirsch A.","year":"2012","unstructured":"Hirsch A.; Hahn D.; Kempn&#xE1; P.; Hofer G.; Nuoffer J.M.; Mullis P.E.; Fl&#xFC;ck C.E.; Metformin inhibits human androgen production by regulating steroidogenic enzymes HSD3B2 and CYP17A1 and complex I activity of the respiratory chain. Endocrinology 2012,153(9),4354-4366","journal-title":"Endocrinology"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"e02242","DOI":"10.7554\/eLife.02242","volume":"3","author":"Wheaton W.W.","year":"2014","unstructured":"Wheaton W.W.; Weinberg S.E.; Hamanaka R.B.; Soberanes S.; Sullivan L.B.; Anso E.; Glasauer A.; Dufour E.; Mutlu G.M.; Budigner G.S.; Chandel N.S.; Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. eLife 2014,3,e02242","journal-title":"eLife"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1007\/s00125-011-2311-5","volume":"54","author":"Stephenne X.","year":"2011","unstructured":"Stephenne X.; Foretz M.; Taleux N.; van der Zon G.C.; Sokal E.; Hue L.; Viollet B.; Guigas B.; Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status. Diabetologia 2011,54(12),3101-3110","journal-title":"Diabetologia"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1074\/jbc.RA118.006670","volume":"294","author":"Alshawi A.","year":"2019","unstructured":"Alshawi A.; Agius L.; Low metformin causes a more oxidized mitochondrial NADH\/NAD redox state in hepatocytes and inhibits gluconeogenesis by a redox-independent mechanism. J Biol Chem 2019,294(8),2839-2853","journal-title":"J Biol Chem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cmet.2005.06.005","volume":"2","author":"Woods A.","year":"2005","unstructured":"Woods A.; Dickerson K.; Heath R.; Hong S.P.; Momcilovic M.; Johnstone S.R.; Carlson M.; Carling D.; Ca2+\/calmodulin-dependent protein kinase kinase-&#x3B2; acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2005,2(1),21-33","journal-title":"Cell Metab"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"E1308","DOI":"10.1152\/ajpendo.00456.2006","volume":"292","author":"Jensen T.E.","year":"2007","unstructured":"Jensen T.E.; Rose A.J.; J&#xF8;rgensen S.B.; Brandt N.; Schjerling P.; Wojtaszewski J.F.P.; Richter E.A.; Possible CaMKK-dependent regulation of AMPK phosphorylation and glucose uptake at the onset of mild tetanic skeletal muscle contraction. Am J Physiol Endocrinol Metab 2007,292(5),E1308-E1317","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/emboj.2009.8","volume":"28","author":"Herrero-Mart&#xED;n G.","year":"2009","unstructured":"Herrero-Mart&#xED;n G.; H&#xF8;yer-Hansen M.; Garc&#xED;a-Garc&#xED;a C.; Fumarola C.; Farkas T.; L&#xF3;pez-Rivas A.; J&#xE4;&#xE4;ttel&#xE4; M.; TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells. EMBO J 2009,28(6),677-685","journal-title":"EMBO J"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11010-013-1568-z","volume":"377","author":"Chen Z.","year":"2013","unstructured":"Chen Z.; Shen X.; Shen F.; Zhong W.; Wu H.; Liu S.; Lai J.; TAK1 activates AMPK-dependent cell death pathway in hydrogen peroxide-treated cardiomyocytes, inhibited by heat shock protein-70. Mol Cell Biochem 2013,377(1-2),35-44","journal-title":"Mol Cell Biochem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"10588","DOI":"10.1074\/jbc.M114.626259","volume":"290","author":"Joseph B.K.","year":"2015","unstructured":"Joseph B.K.; Liu H.Y.; Francisco J.; Pandya D.; Donigan M.; Gallo-Ebert C.; Giordano C.; Bata A.; Nickels J.T.; Jr Inhibition of AMP kinase by the protein phosphatase 2A heterotrimer, PP2APpp2r2d. J Biol Chem 2015,290(17),10588-10598","journal-title":"J Biol Chem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0014-5793(95)01368-7","volume":"377","author":"Davies S.P.","year":"1995","unstructured":"Davies S.P.; Helps N.R.; Cohen P.T.W.; Hardie D.G.; 5\u2032-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C &#x3B1; and native bovine protein phosphatase-2AC. FEBS Lett 1995,377(3),421-425","journal-title":"FEBS Lett"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature09932","volume":"472","author":"Xiao B.","year":"2011","unstructured":"Xiao B.; Sanders M.J.; Underwood E.; Heath R.; Mayer F.V.; Carmena D.; Jing C.; Walker P.A.; Eccleston J.F.; Haire L.F.; Saiu P.; Howell S.A.; Aasland R.; Martin S.R.; Carling D.; Gamblin S.J.; Structure of mammalian AMPK and its regulation by ADP. Nature 2011,472(7342),230-233","journal-title":"Nature"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cmet.2013.08.019","volume":"18","author":"Gowans G.J.","year":"2013","unstructured":"Gowans G.J.; Hawley S.A.; Ross F.A.; Hardie D.G.; AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation. Cell Metab 2013,18(4),556-566","journal-title":"Cell Metab"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1038\/emm.2016.81","volume":"48","author":"Jeon S.M.","year":"2016","unstructured":"Jeon S.M.; Regulation and function of AMPK in physiology and diseases. Exp Mol Med 2016,48(7),e245","journal-title":"Exp Mol Med"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature13270","volume":"510","author":"Madiraju A.K.","year":"2014","unstructured":"Madiraju A.K.; Erion D.M.; Rahimi Y.; Zhang X.M.; Braddock D.T.; Albright R.A.; Prigaro B.J.; Wood J.L.; Bhanot S.; MacDonald M.J.; Jurczak M.J.; Camporez J.P.; Lee H.Y.; Cline G.W.; Samuel V.T.; Kibbey R.G.; Shulman G.I.; Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 2014,510(7506),542-546","journal-title":"Nature"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/s41591-018-0125-4","volume":"24","author":"Madiraju A.K.","year":"2018","unstructured":"Madiraju A.K.; Qiu Y.; Perry R.J.; Rahimi Y.; Zhang X.M.; Zhang D.; Camporez J.G.; Cline G.W.; Butrico G.M.; Kemp B.E.; Casals G.; Steinberg G.R.; Vatner D.F.; Petersen K.F.; Shulman G.I.; Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo. Nat Med 2018,24(9),1384-1394","journal-title":"Nat Med"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1365-2796.2010.02218.x","volume":"267","author":"Straub R.H.","year":"2010","unstructured":"Straub R.H.; Cutolo M.; Buttgereit F.; Pongratz G.; Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. J Intern Med 2010,267(6),543-560","journal-title":"J Intern Med"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0026-0495(95)90255-4","volume":"44","author":"Blumberg D.","year":"1995","unstructured":"Blumberg D.; Hochwald S.; Brennan M.F.; Burt M.; Interleukin-6 stimulates gluconeogenesis in primary cultures of rat hepatocytes. Metabolism 1995,44(2),145-146","journal-title":"Metabolism"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"32178","DOI":"10.1074\/jbc.M114.601096","volume":"289","author":"Zhang W.","year":"2014","unstructured":"Zhang W.; Mottillo E.P.; Zhao J.; Gartung A.; VanHecke G.C.; Lee J.F.; Maddipati K.R.; Xu H.; Ahn Y.H.; Proia R.L.; Granneman J.G.; Lee M.J.; Adipocyte lipolysis-stimulated interleukin-6 production requires sphingosine kinase 1 activity. J Biol Chem 2014,289(46),32178-32185","journal-title":"J Biol Chem"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"E727","DOI":"10.1152\/ajpendo.1991.260.5.E727","volume":"260","author":"Goodman M.N.","year":"1991","unstructured":"Goodman M.N.; Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol 1991,260(5 Pt 1),E727-E730","journal-title":"Am J Physiol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3181\/00379727-205-43695","volume":"205","author":"Goodman M.N.","year":"1994","unstructured":"Goodman M.N.; Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc Soc Exp Biol Med 1994,205(2),182-185","journal-title":"Proc Soc Exp Biol Med"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1017\/S000711450769936X","volume":"98","author":"Li P.","year":"2007","unstructured":"Li P.; Yin Y.L.; Li D.; Kim S.W.; Wu G.; Amino acids and immune function. Br J Nutr 2007,98(2),237-252","journal-title":"Br J Nutr"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"Saxton R.A.","year":"2017","unstructured":"Saxton R.A.; Sabatini D.M.; mTOR signaling in growth, metabolism, and disease. Cell 2017,168(6),960-976","journal-title":"Cell"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/S0006-2952(02)00861-4","volume":"63","author":"Kiersztan A.","year":"2002","unstructured":"Kiersztan A.; Modzelewska A.; Jarzyna R.; Jagielska E.; Bry\u0142a, J. Inhibition of gluconeogenesis by vanadium and metformin in kidney-cortex tubules isolated from control and diabetic rabbits. Biochem Pharmacol 2002,63(7),1371-1382","journal-title":"Biochem Pharmacol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1677\/jme.1.02061","volume":"37","author":"Ren T.","year":"2006","unstructured":"Ren T.; He J.; Jiang H.; Zu L.; Pu S.; Guo X.; Xu G.; Metformin reduces lipolysis in primary rat adipocytes stimulated by tumor necrosis factor-&#x3B1; or isoproterenol. J Mol Endocrinol 2006,37(1),175-183","journal-title":"J Mol Endocrinol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3109\/13813455.2010.550925","volume":"117","author":"Grisouard J.","year":"2011","unstructured":"Grisouard J.; Timper K.; Bouillet E.; Radimerski T.; Dembinski K.; Frey D.M.; Peterli R.; Zulewski H.; Keller U.; M&#xFC;ller B.; Christ-Crain M.; Metformin counters both lipolytic\/inflammatory agents-decreased hormone sensitive lipase phosphorylation at Ser-554 and -induced lipolysis in human adipocytes. Arch Physiol Biochem 2011,117(4),209-214","journal-title":"Arch Physiol Biochem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13410-020-00868-7","volume":"40","author":"Bhandari S.","year":"2020","unstructured":"Bhandari S.; Rankawat G.; Singh A.; Gupta V.; Kakkar S.; Impact of glycemic control in diabetes mellitus on management of COVID-19 infection. Int J Diabetes Dev Ctries 2020,40(3),1-6","journal-title":"Int J Diabetes Dev Ctries"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"695139","DOI":"10.3389\/fpubh.2021.695139","volume":"9","author":"Logette E.","year":"2021","unstructured":"Logette E.; Lorin C.; Favreau C.; Oshurko E.; Coggan J.S.; Casalegno F.; Sy M.F.; Monney C.; Bertschy M.; Delattre E.; Fonta P.A.; Krepl J.; Schmidt S.; Keller D.; Kerrien S.; Scantamburlo E.; Kaufmann A.K.; Markram H.; A machine-generated view of the role of blood glucose levels in the severity of COVID-19. Front Public Health 2021,9,695139","journal-title":"Front Public Health"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.mam.2012.10.010","volume":"34","author":"Koepsell H.","year":"2013","unstructured":"Koepsell H.; The SLC22 family with transporters of organic cations, anions and zwitterions. Mol Aspects Med 2013,34(2-3),413-435","journal-title":"Mol Aspects Med"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12931-018-0760-9","volume":"19","author":"Berg T.","year":"2018","unstructured":"Berg T.; Hegelund-Myrb&#xE4;ck T.; &#xD6;ckinger J.; Zhou X.H.; Br&#xE4;nnstr&#xF6;m M.; Hagemann-Jensen M.; Werkstr&#xF6;m V.; Seideg&#xE5;rd J.; Grunewald J.; Nord M.; Gustavsson L.; Expression of MATE1, P-gp, OCTN1 and OCTN2, in epithelial and immune cells in the lung of COPD and healthy individuals. Respir Res 2018,19(1),68","journal-title":"Respir Res"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"973986","DOI":"10.1155\/2014\/973986","volume":"2014","author":"Son H.J.","year":"2014","unstructured":"Son H.J.; Lee J.; Lee S.Y.; Kim E.K.; Park M.J.; Kim K.W.; Park S.H.; Cho M.L.; Metformin attenuates experimental autoimmune arthritis through reciprocal regulation of Th17\/Treg balance and osteoclastogenesis. Mediators Inflamm 2014,2014,973986","journal-title":"Mediators Inflamm"},{"key":"ref=109","first-page":"2393","volume":"11","author":"Duan W.","year":"2019","unstructured":"Duan W.; Ding Y.; Yu X.; Ma D.; Yang B.; Li Y.; Huang L.; Chen Z.; Zheng J.; Yang C.; Metformin mitigates autoimmune insulitis by inhibiting Th1 and Th17 responses while promoting Treg production. Am J Transl Res 2019,11(4),2393-2402","journal-title":"Am J Transl Res"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"780S","DOI":"10.3945\/an.115.011031","volume":"7","author":"Kilberg M.S.","year":"2016","unstructured":"Kilberg M.S.; Terada N.; Shan J.; Influence of amino acid metabolism on embryonic stem cell function and differentiation. Adv Nutr 2016,7(4),780S-789S","journal-title":"Adv Nutr"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.3389\/fimmu.2019.02839","volume":"10","author":"Kempkes R.W.M.","year":"2019","unstructured":"Kempkes R.W.M.; Joosten I.; Koenen H.J.P.M.; He X.; Metabolic pathways involved in regulatory T cell functionality. Front Immunol 2019,10,2839","journal-title":"Front Immunol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"20534","DOI":"10.1074\/jbc.M611782200","volume":"282","author":"Land S.C.","year":"2007","unstructured":"Land S.C.; Tee A.R.; Hypoxia-inducible factor 1&#x3B1; is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J Biol Chem 2007,282(28),20534-20543","journal-title":"J Biol Chem"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","volume":"39","author":"D&#xFC;vel K.","year":"2010","unstructured":"D&#xFC;vel K.; Yecies J.L.; Menon S.; Raman P.; Lipovsky A.I.; Souza A.L.; Triantafellow E.; Ma Q.; Gorski R.; Cleaver S.; Vander Heiden M.G.; MacKeigan J.P.; Finan P.M.; Clish C.B.; Murphy L.O.; Manning B.D.; Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 2010,39(2),171-183","journal-title":"Mol Cell"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41423-019-0344-8","volume":"17","author":"Zhao Y.","year":"2020","unstructured":"Zhao Y.; Shao Q.; Peng G.; Exhaustion and senescence: Two crucial dysfunctional states of T cells in the tumor microenvironment. Cell Mol Immunol 2020,17(1),27-35","journal-title":"Cell Mol Immunol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/acel.12380","volume":"14","author":"Hurez V.","year":"2015","unstructured":"Hurez V.; Dao V.; Liu A.; Pandeswara S.; Gelfond J.; Sun L.; Bergman M.; Orihuela C.J.; Galvan V.; Padr&#xF3;n &#xC1;.; Drerup J.; Liu Y.; Hasty P.; Sharp Z.D.; Curiel T.J.; Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice. Aging Cell 2015,14(6),945-956","journal-title":"Aging Cell"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4062\/biomolther.2012.094","volume":"21","author":"Shin S.","year":"2013","unstructured":"Shin S.; Hyun B.; Lee A.; Kong H.; Han S.; Lee C.K.; Ha N.J.; Kim K.; Metformin suppresses MHC-restricted antigen presentation by inhibiting co-stimulatory factors and MHC molecules in APCs. Biomol Ther (Seoul) 2013,21(1),35-41","journal-title":"Biomol Ther (Seoul)"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/j.molcel.2021.03.037","volume":"81","author":"Dai X.","year":"2021","unstructured":"Dai X.; Bu X.; Gao Y.; Guo J.; Hu J.; Jiang C.; Zhang Z.; Xu K.; Duan J.; He S.; Zhang J.; Wan L.; Liu T.; Zhou X.; Hung M.C.; Freeman G.J.; Wei W.; Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade. Mol Cell 2021,81(11),2317-2331.e6","journal-title":"Mol Cell"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.molcel.2018.07.030","volume":"71","author":"Cha J.H.","year":"2018","unstructured":"Cha J.H.; Yang W.H.; Xia W.; Wei Y.; Chan L.C.; Lim S.O.; Li C.W.; Kim T.; Chang S.S.; Lee H.H.; Hsu J.L.; Wang H.L.; Kuo C.W.; Chang W.C.; Hadad S.; Purdie C.A.; McCoy A.M.; Cai S.; Tu Y.; Litton J.K.; Mittendorf E.A.; Moulder S.L.; Symmans W.F.; Thompson A.M.; Piwnica-Worms H.; Chen C.H.; Khoo K.H.; Hung M.C.; Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1. Mol Cell 2018,71(4),606-620.e7","journal-title":"Mol Cell"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"2007149","DOI":"10.1002\/adfm.202007149","volume":"31","author":"Hu C.","year":"2021","unstructured":"Hu C.; He X.; Chen Y.; Yang X.; Qin L.; Lei T.; Zhou Y.; Gong T.; Huang Y.; Gao H.; Metformin mediated PD-L1 downregulation in combination with photodynamic-immunotherapy for treatment of breast cancer. Adv Funct Mater 2021,31(11),2007149","journal-title":"Adv Funct Mater"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1084\/jem.20190550","volume":"216","author":"Sun X.","year":"2019","unstructured":"Sun X.; Cui Y.; Feng H.; Liu H.; Liu X.; TGF-&#x3B2; signaling controls Foxp3 methylation and T reg cell differentiation by modulating Uhrf1 activity. J Exp Med 2019,216(12),2819-2837","journal-title":"J Exp Med"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"12542","DOI":"10.1073\/pnas.1715363114","volume":"114","author":"He N.","year":"2017","unstructured":"He N.; Fan W.; Henriquez B.; Yu R.T.; Atkins A.R.; Liddle C.; Zheng Y.; Downes M.; Evans R.M.; Metabolic control of regulatory T cell (Treg) survival and function by Lkb1. Proc Natl Acad Sci USA 2017,114(47),12542-12547","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"8633","DOI":"10.4049\/jimmunol.181.12.8633","volume":"181","author":"Sag D.","year":"2008","unstructured":"Sag D.; Carling D.; Stout R.D.; Suttles J.; Adenosine 5\u2032-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J Immunol 2008,181(12),8633-8641","journal-title":"J Immunol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"108","DOI":"10.33696\/immunology.2.029","volume":"2","author":"Ahmed I.","year":"2020","unstructured":"Ahmed I.; Ismail N.; M1 and M2 macrophages polarization via mTORc1 influences innate immunity and outcome of Ehrlichia infection. J Cell Immunol 2020,2(3),108-115","journal-title":"J Cell Immunol"},{"key":"ref=124","first-page":"655","volume":"11","author":"Qing L.","year":"2019","unstructured":"Qing L.; Fu J.; Wu P.; Zhou Z.; Yu F.; Tang J.; Metformin induces the M2 macrophage polarization to accelerate the wound healing via regulating AMPK\/mTOR\/NLRP3 inflammasome singling pathway. Am J Transl Res 2019,11(2),655-668","journal-title":"Am J Transl Res"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1080\/15321819.2020.1862861","volume":"42","author":"Amoani B.","year":"2021","unstructured":"Amoani B.; Sakyi S.A.; Mantey R.; Laing E.F.; Ephraim R.D.; Sarfo-Katanka O.; Koffie S.; Obese E.; Afranie B.O.; Increased metformin dosage suppresses pro-inflammatory cytokine levels in systemic circulation and might contribute to its beneficial effects. J Immunoassay Immunochem 2021,42(3),252-264","journal-title":"J Immunoassay Immunochem"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1006\/cimm.1999.1490","volume":"194","author":"Santos-Alvarez J.","year":"1999","unstructured":"Santos-Alvarez J.; Goberna R.; S&#xE1;nchez-Margalet V.; Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 1999,194(1),6-11","journal-title":"Cell Immunol"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1006\/cimm.1999.1594","volume":"199","author":"Mart&#xED;n-Romero C.","year":"2000","unstructured":"Mart&#xED;n-Romero C.; Santos-Alvarez J.; Goberna R.; S&#xE1;nchez-Margalet V.; Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol 2000,199(1),15-24","journal-title":"Cell Immunol"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.4049\/jimmunol.1200935","volume":"189","author":"Procaccini C.","year":"2012","unstructured":"Procaccini C.; De Rosa V.; Galgani M.; Carbone F.; Cassano S.; Greco D.; Qian K.; Auvinen P.; Cal&#xEC; G.; Stallone G.; Formisano L.; La Cava A.; Matarese G.; Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses. J Immunol 2012,189(6),2941-2953","journal-title":"J Immunol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"e04696","DOI":"10.1016\/j.heliyon.2020.e04696","volume":"6","author":"van der Voort P.H.J.","year":"2020","unstructured":"van der Voort P.H.J.; Moser J.; Zandstra D.F.; Muller Kobold A.C.; Knoester M.; Calkhoven C.F.; Hamming I.; van Meurs M.; Leptin levels in SARS-CoV-2 infection related respiratory failure: A cross-sectional study and a pathophysiological framework on the role of fat tissue. Heliyon 2020,6(8),e04696","journal-title":"Heliyon"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/JLB.5HI1020-704R","volume":"110","author":"Wang J.","year":"2021","unstructured":"Wang J.; Xu Y.; Zhang X.; Wang S.; Peng Z.; Guo J.; Jiang H.; Liu J.; Xie Y.; Wang J.; Li X.; Liao J.; Wan C.; Yu L.; Hu J.; Liu B.; Liu Z.; Leptin correlates with monocytes activation and severe condition in COVID-19 patients. J Leukoc Biol 2021,110(1),9-20","journal-title":"J Leukoc Biol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S0925-4439(00)00074-0","volume":"1502","author":"Mick G.J.","year":"2000","unstructured":"Mick G.J.; Wang X.; Ling Fu; C.; McCormick, K.L. Inhibition of leptin secretion by insulin and metformin in cultured rat adipose tissue. Biochim Biophys Acta 2000,1502(3),426-432","journal-title":"Biochim Biophys Acta"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1677\/joe.1.05646","volume":"183","author":"Klein J.","year":"2004","unstructured":"Klein J.; Westphal S.; Kraus D.; Meier B.; Perwitz N.; Ott V.; Fasshauer M.; Klein H.H.; Metformin inhibits leptin secretion via a mitogen-activated protein kinase signalling pathway in brown adipocytes. J Endocrinol 2004,183(2),299-307","journal-title":"J Endocrinol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2337\/diabetes.55.03.06.db05-0917","volume":"55","author":"Kim Y.W.","year":"2006","unstructured":"Kim Y.W.; Kim J.Y.; Park Y.H.; Park S.Y.; Won K.C.; Choi K.H.; Huh J.Y.; Moon K.H.; Metformin restores leptin sensitivity in high-fat-fed obese rats with leptin resistance. Diabetes 2006,55(3),716-724","journal-title":"Diabetes"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"9","DOI":"10.17877\/DE290R-1136","volume":"10","author":"Upadhyaya P.","year":"2011","unstructured":"Upadhyaya P.; Rehan H.S.; Seth V.; Serum leptin changes with metformin treatment in polycystic ovarian syndrome: Correlation with ovulation, insulin and testosterone levels. EXCLI J 2011,10,9-15","journal-title":"EXCLI J"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.tips.2015.11.011","volume":"37","author":"Cai H.","year":"2016","unstructured":"Cai H.; Dong L.Q.; Liu F.; Recent advances in adipose mTOR signaling and function: Therapeutic prospects. Trends Pharmacol Sci 2016,37(4),303-317","journal-title":"Trends Pharmacol Sci"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1111\/jcmm.16269","volume":"25","author":"Guo Y.","year":"2021","unstructured":"Guo Y.; Shi J.; Wang Q.; Hong L.; Chen M.; Liu S.; Yuan X.; Jiang S.; Metformin alleviates allergic airway inflammation and increases Treg cells in obese asthma. J Cell Mol Med 2021,25(4),2279-2284","journal-title":"J Cell Mol Med"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.bcp.2012.09.025","volume":"84","author":"Park C.S.","year":"2012","unstructured":"Park C.S.; Bang B.R.; Kwon H.S.; Moon K.A.; Kim T.B.; Lee K.Y.; Moon H.B.; Cho Y.S.; Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase. Biochem Pharmacol 2012,84(12),1660-1670","journal-title":"Biochem Pharmacol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-3083.2009.02319.x","volume":"70","author":"Brandtzaeg P.","year":"2009","unstructured":"Brandtzaeg P.; Mucosal immunity: Induction, dissemination, and effector functions. Scand J Immunol 2009,70(6),505-515","journal-title":"Scand J Immunol"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/ni.3780","volume":"18","author":"Blander J.M.","year":"2017","unstructured":"Blander J.M.; Longman R.S.; Iliev I.D.; Sonnenberg G.F.; Artis D.; Regulation of inflammation by microbiota interactions with the host. Nat Immunol 2017,18(8),851-860","journal-title":"Nat Immunol"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"607734","DOI":"10.3389\/fimmu.2020.607734","volume":"11","author":"Vignesh R.","year":"2021","unstructured":"Vignesh R.; Swathirajan C.R.; Tun Z.H.; Rameshkumar M.R.; Solomon S.S.; Balakrishnan P.; Could perturbation of gut microbiota possibly exacerbate the severity of COVID-19 via cytokine storm? Front Immunol 2021,11(January),607734","journal-title":"Front Immunol"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1053\/j.gastro.2020.05.048","volume":"159","author":"Zuo T.","year":"2020","unstructured":"Zuo T.; Zhang F.; Lui G.C.Y.; Yeoh Y.K.; Li A.Y.L.; Zhan H.; Wan Y.; Chung A.C.K.; Cheung C.P.; Chen N.; Lai C.K.C.; Chen Z.; Tso E.Y.K.; Fung K.S.C.; Chan V.; Ling L.; Joynt G.; Hui D.S.C.; Chan F.K.L.; Chan P.K.S.; Ng S.C.; Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology 2020,159(3),944-955.e8","journal-title":"Gastroenterology"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2337\/dc16-1324","volume":"40","author":"de la Cuesta-Zuluaga J.","year":"2017","unstructured":"de la Cuesta-Zuluaga J.; Mueller N.T.; Corrales-Agudelo V.; Vel&#xE1;squez-Mej&#xED;a E.P.; Carmona J.A.; Abad J.M.; Escobar J.S.; Metformin is associated with higher relative abundance of mucin-degrading akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut. Diabetes Care 2017,40(1),54-62","journal-title":"Diabetes Care"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1007\/s00125-019-4848-7","volume":"62","author":"Bryrup T.","year":"2019","unstructured":"Bryrup T.; Thomsen C.W.; Kern T.; Allin K.H.; Brandslund I.; J&#xF8;rgensen N.R.; Vestergaard H.; Hansen T.; Hansen T.H.; Pedersen O.; Nielsen T.; Metformin-induced changes of the gut microbiota in healthy young men: Results of a non-blinded, one-armed intervention study. Diabetologia 2019,62(6),1024-1035","journal-title":"Diabetologia"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"e0204317","DOI":"10.1371\/journal.pone.0204317","volume":"13","author":"Elbere I.","year":"2018","unstructured":"Elbere I.; Kalnina I.; Silamikelis I.; Konrade I.; Zaharenko L.; Sekace K.; Radovica-Spalvina I.; Fridmanis D.; Gudra D.; Pirags V.; Klovins J.; Association of metformin administration with gut microbiome dysbiosis in healthy volunteers. PLoS One 2018,13(9),e0204317","journal-title":"PLoS One"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4103\/2231-4040.90879","volume":"2","author":"Tyagi S.","year":"2011","unstructured":"Tyagi S.; Gupta P.; Saini A.S.; Kaushal C.; Sharma S.; The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases. J Adv Pharm Technol Res 2011,2(4),236-240","journal-title":"J Adv Pharm Technol Res"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.2337\/diabetes.50.10.2296","volume":"50","author":"Shintani M.","year":"2001","unstructured":"Shintani M.; Nishimura H.; Yonemitsu S.; Ogawa Y.; Hayashi T.; Hosoda K.; Inoue G.; Nakao K.; Troglitazone not only increases GLUT4 but also induces its translocation in rat adipocytes. Diabetes 2001,50(10),2296-2300","journal-title":"Diabetes"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.bcp.2009.12.013","volume":"79","author":"Martinez L.","year":"2010","unstructured":"Martinez L.; Berenguer M.; Bruce M.C.; Le Marchand-Brustel Y.; Govers R.; Rosiglitazone increases cell surface GLUT4 levels in 3T3-L1 adipocytes through an enhancement of endosomal recycling. Biochem Pharmacol 2010,79(9),1300-1309","journal-title":"Biochem Pharmacol"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1210\/endo.143.5.8812","volume":"143","author":"Standaert M.L.","year":"2002","unstructured":"Standaert M.L.; Kanoh Y.; Sajan M.P.; Bandyopadhyay G.; Farese R.V.; Cbl, IRS-1, and IRS-2 mediate effects of rosiglitazone on PI3K, PKC-&#x3BB; and glucose transport in 3T3\/L1 adipocytes. Endocrinology 2002,143(5),1705-1716","journal-title":"Endocrinology"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00125-002-1002-7","volume":"46","author":"Hammarstedt A.","year":"2003","unstructured":"Hammarstedt A.; Smith U.; Thiazolidinediones (PPARgamma ligands) increase IRS-1, UCP-2 and C\/EBPalpha expression, but not transdifferentiation, in L6 muscle cells. Diabetologia 2003,46(1),48-52","journal-title":"Diabetologia"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"22426","DOI":"10.1074\/jbc.M109.028357","volume":"284","author":"Zhou L.","year":"2009","unstructured":"Zhou L.; Deepa S.S.; Etzler J.C.; Ryu J.; Mao X.; Fang Q.; Liu D.D.; Torres J.M.; Jia W.; Lechleiter J.D.; Liu F.; Dong L.Q.; Adiponectin activates AMP-activated protein kinase in muscle cells via APPL1\/LKB1-dependent and phospholipase C\/Ca2+\/Ca2+\/calmodulin-dependent protein kinase kinase-dependent pathways. J Biol Chem 2009,284(33),22426-22435","journal-title":"J Biol Chem"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3858\/emm.2009.41.8.063","volume":"41","author":"Yoon Y.S.","year":"2009","unstructured":"Yoon Y.S.; Ryu D.; Lee M.W.; Hong S.; Koo S.H.; Adiponectin and thiazolidinedione targets CRTC2 to regulate hepatic gluconeogenesis. Exp Mol Med 2009,41(8),577-583","journal-title":"Exp Mol Med"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.1074\/jbc.M109.088708","volume":"285","author":"Ohashi K.","year":"2010","unstructured":"Ohashi K.; Parker J.L.; Ouchi N.; Higuchi A.; Vita J.A.; Gokce N.; Pedersen A.A.; Kalthoff C.; Tullin S.; Sams A.; Summer R.; Walsh K.; Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem 2010,285(9),6153-6160","journal-title":"J Biol Chem"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"H656","DOI":"10.1152\/ajpheart.00115.2010","volume":"299","author":"Lovren F.","year":"2010","unstructured":"Lovren F.; Pan Y.; Quan A.; Szmitko P.E.; Singh K.K.; Shukla P.C.; Gupta M.; Chan L.; Al-Omran M.; Teoh H.; Verma S.; Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages. Am J Physiol Heart Circ Physiol 2010,299(3),H656-H663","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"1220-1225","DOI":"10.1152\/ajpregu.00397.2004","volume":"288","author":"Ajuwon K. M.","year":"2005","unstructured":"Ajuwon K. M.; Spurlock M. E.; Adiponectin inhibits LPS-induced NF-KB activation and IL-6 production and increases PPAR&#x3B3;2 expression in adipocytes. Am. J. Physiol. - Regul. Integr. Comp. Physiol 2005,288(5 57-5),1220-1225"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"24889","DOI":"10.1074\/jbc.M804236200","volume":"283","author":"Chandrasekar B.","year":"2008","unstructured":"Chandrasekar B.; Boylston W.H.; Venkatachalam K.; Webster N.J.G.; Prabhu S.D.; Valente A.J.; Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase (AMPK) activation and IKK\/NF-kappaB\/PTEN suppression. J Biol Chem 2008,283(36),24889-24898","journal-title":"J Biol Chem"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"e14843","DOI":"10.14814\/phy2.14843","volume":"9","author":"Kearns S.M.","year":"2021","unstructured":"Kearns S.M.; Ahern K.W.; Patrie J.T.; Horton W.B.; Harris T.E.; Kadl A.; Reduced adiponectin levels in patients with COVID-19 acute respiratory failure: A case-control study. Physiol Rep 2021,9(7),e14843","journal-title":"Physiol Rep"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"101268","DOI":"10.1016\/j.diabet.2021.101268","volume":"47","author":"Di Filippo L.","year":"2021","unstructured":"Di Filippo L.; De Lorenzo R.; Sciorati C.; Capobianco A.; Lor&#xE8; N.I.; Giustina A.; Manfredi A.A.; Rovere-Querini P.; Conte C.; Adiponectin to leptin ratio reflects inflammatory burden and survival in COVID-19. Diabetes Metab 2021,47(6),101268","journal-title":"Diabetes Metab"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1053\/j.gastro.2020.05.057","volume":"159","author":"El-Kurdi B.","year":"2020","unstructured":"El-Kurdi B.; Khatua B.; Rood C.; Snozek C.; Cartin-Ceba R.; Singh V.P.; El-Kurdi B.; Khatua B.; Rood C.; Snozek C.; Kostenko S.; Trivedi S.; Folmes C.; Dykhouse K.M.; Babar S.; Chang Y-H.; Pannala R.; Cartin-Ceba R.; Singh V.P.; Mortality from coronavirus disease 2019 increases with unsaturated fat and may be reduced by early calcium and albumin supplementation. Gastroenterology 2020,159(3),1015-1018.e4","journal-title":"Gastroenterology"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1053\/j.gastro.2020.07.014","volume":"159","author":"Hegyi P.","year":"2020","unstructured":"Hegyi P.; Szak&#xE1;cs Z.; Sahin-T&#xF3;th M.; Lipotoxicity and cytokine storm in severe acute pancreatitis and COVID-19. Gastroenterology 2020,159(3),824-827","journal-title":"Gastroenterology"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"18785","DOI":"10.1074\/jbc.M206999200","volume":"278","author":"Tordjman J.","year":"2003","unstructured":"Tordjman J.; Chauvet G.; Quette J.; Beale E.G.; Forest C.; Antoine B.; Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells. J Biol Chem 2003,278(21),18785-18790","journal-title":"J Biol Chem"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.metabol.2015.02.005","volume":"64","author":"He J.","year":"2015","unstructured":"He J.; Xu C.; Kuang J.; Liu Q.; Jiang H.; Mo L.; Geng B.; Xu G.; Thiazolidinediones attenuate lipolysis and ameliorate dexamethasone-induced insulin resistance. Metabolism 2015,64(7),826-836","journal-title":"Metabolism"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"880","DOI":"10.2337\/diabetes.54.3.880","volume":"54","author":"Boden G.","year":"2005","unstructured":"Boden G.; Homko C.; Mozzoli M.; Showe L.C.; Nichols C.; Cheung P.; Thiazolidinediones upregulate fatty acid uptake and oxidation in adipose tissue of diabetic patients. Diabetes 2005,54(3),880-885","journal-title":"Diabetes"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"0634-0647","DOI":"10.1371\/journal.pgen.0030064","volume":"3","author":"Medina-Gomez G.","year":"2007","unstructured":"Medina-Gomez G.; Gray S. L.; Yetukuri L.; Shimomura K.; Virtue S.; Campbell M.; Curtis R. K.; Jimenez-Linan M.; Blount M.; Yeo G. S. H.; PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet, 2007,3(4),0634-0647"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.livres.2018.12.001","volume":"2","author":"Lee Y.K.","year":"2018","unstructured":"Lee Y.K.; Park J.E.; Lee M.; Hardwick J.P.; Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2. Liver Res 2018,2(4),209-215","journal-title":"Liver Res"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/1753425913501565","volume":"20","author":"Kaplan J.","year":"2014","unstructured":"Kaplan J.; Nowell M.; Chima R.; Zingarelli B.; Pioglitazone reduces inflammation through inhibition of NF-&#x3BA;B in polymicrobial sepsis. Innate Immun 2014,20(5),519-528","journal-title":"Innate Immun"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s10753-015-0193-2","volume":"38","author":"Zhang Y.F.","year":"2015","unstructured":"Zhang Y.F.; Zou X.L.; WU, J.; Yu, X.Q.; Yang, X. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-&#x3B3; agonist, attenuates inflammation via NF-KB inhibition in lipopolysaccharide-induced peritonitis. Inflammation 2015,38(6),2105-2115","journal-title":"Inflammation"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1097\/CCM.0b013e318187810e","volume":"36","author":"Chima R.S.","year":"2008","unstructured":"Chima R.S.; Hake P.W.; Piraino G.; Mangeshkar P.; Denenberg A.; Zingarelli B.; Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase\/nuclear factor-kappaB pathway after hemorrhagic shock. Crit Care Med 2008,36(10),2849-2857","journal-title":"Crit Care Med"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.bbalip.2007.02.013","volume":"1771","author":"Ricote M.","year":"2007","unstructured":"Ricote M.; Glass C.K.; PPARs and molecular mechanisms of transrepression. Biochim Biophys Acta 2007,1771(8),926-935","journal-title":"Biochim Biophys Acta"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1177\/0194599810396133","volume":"144","author":"Wang W.","year":"2011","unstructured":"Wang W.; Zhu Z.; Zhu B.; Ma Z.; Peroxisome proliferator-activated receptor-gamma agonist induces regulatory T cells in a murine model of allergic rhinitis. Otolaryngol Head Neck Surg 2011,144(4),506-513","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature11132","volume":"486","author":"Cipolletta D.","year":"2012","unstructured":"Cipolletta D.; Feuerer M.; Li A.; Kamei N.; Lee J.; Shoelson S.E.; Benoist C.; Mathis D.; PPAR-&#x3B3; is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 2012,486(7404),549-553","journal-title":"Nature"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-23420-4","volume":"8","author":"Mancini S.J.","year":"2018","unstructured":"Mancini S.J.; Boyd D.; Katwan O.J.; Strembitska A.; Almabrouk T.A.; Kennedy S.; Palmer T.M.; Salt I.P.; Canagliflozin inhibits interleukin-1&#x3B2;-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms. Sci Rep 2018,8(1),1-14","journal-title":"Sci Rep"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"15","DOI":"10.6065\/apem.2017.22.1.15","volume":"22","author":"Lee S.","year":"2017","unstructured":"Lee S.; Lee D.Y.; Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes. Ann Pediatr Endocrinol Metab 2017,22(1),15-26","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"109031","DOI":"10.1016\/j.diabres.2021.109031","volume":"179","author":"Hariyanto T.I.","year":"2021","unstructured":"Hariyanto T.I.; Intan D.; Hananto J.E.; Putri C.; Kurniawan A.; Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression. Diabetes Res Clin Pract 2021,179,109031","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3892\/ijmm.2015.2207","volume":"36","author":"Huang C.","year":"2015","unstructured":"Huang C.; Yuan L.; Cao S.; Endogenous GLP-1 as a key self-defense molecule against lipotoxicity in pancreatic islets. Int J Mol Med 2015,36(1),173-185","journal-title":"Int J Mol Med"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.bbrc.2018.07.090","volume":"503","author":"Yang Y.","year":"2018","unstructured":"Yang Y.; Lu Y.; Han F.; Chang Y.; Li X.; Han Z.; Xue M.; Cheng Y.; Sun B.; Chen L.; Saxagliptin regulates M1\/M2 macrophage polarization via CaMKK&#x3B2;\/AMPK pathway to attenuate NAFLD. Biochem Biophys Res Commun 2018,503(3),1618-1624","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"e000227","DOI":"10.1136\/bmjdrc-2016-000227","volume":"4","author":"Birnbaum Y.","year":"2016","unstructured":"Birnbaum Y.; Bajaj M.; Qian J.; Ye Y.; Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3\/ASC inflammasome. BMJ Open Diabetes Res Care 2016,4(1),e000227","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1007\/s10753-018-0845-0","volume":"41","author":"Liu Q.","year":"2018","unstructured":"Liu Q.; Zhang L.; Zhang W.; Hao Q.; Qiu W.; Wen Y.; Wang H.; Li X.; Inhibition of NF-&#x3BA;B reduces renal inflammation and expression of PEPCK in type 2 diabetic Mice. Inflammation 2018,41(6),2018-2029","journal-title":"Inflammation"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cmet.2013.12.008","volume":"19","author":"Longo V.D.","year":"2014","unstructured":"Longo V.D.; Mattson M.P.; Fasting: Molecular mechanisms and clinical applications. Cell Metab 2014,19(2),181-192","journal-title":"Cell Metab"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11892-017-0951-7","volume":"17","author":"Golbidi S.","year":"2017","unstructured":"Golbidi S.; Daiber A.; Korac B.; Li H.; Essop M.F.; Laher I.; Health benefits of fasting and caloric restriction. Curr Diab Rep 2017,17(12),123","journal-title":"Curr Diab Rep"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"b013","DOI":"10.1093\/immadv\/ltab013","volume":"1","author":"O\u2019Carroll S.M.","year":"2021","unstructured":"O\u2019Carroll S.M.; O\u2019Neill L.A.J.; Targeting immunometabolism to treat COVID-19. Immunother Adv 2021,1(1),b013","journal-title":"Immunother Adv"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S2213-2600(21)00218-6","volume":"9","author":"Osuchowski M.F.","year":"2021","unstructured":"Osuchowski M.F.; Winkler M.S.; Skirecki T.; Cajander S.; Shankar-Hari M.; Lachmann G.; Monneret G.; Venet F.; Bauer M.; Brunkhorst F.M.; Weis S.; Garcia-Salido A.; Kox M.; Cavaillon J.M.; Uhle F.; Weigand M.A.; Floh&#xE9; S.B.; Wiersinga W.J.; Almansa R.; de la Fuente A.; Martin-Loeches I.; Meisel C.; Spinetti T.; Schefold J.C.; Cilloniz C.; Torres A.; Giamarellos-Bourboulis E.J.; Ferrer R.; Girardis M.; Cossarizza A.; Netea M.G.; van der Poll T.; Bermejo-Mart&#xED;n J.F.; Rubio I.; The COVID-19 puzzle: Deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir Med 2021,9(6),622-642","journal-title":"Lancet Respir Med"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms18122755","volume":"18","author":"Burns J.S.","year":"2017","unstructured":"Burns J.S.; Manda G.; Metabolic pathways of the warburg effect in health and disease: Perspectives of choice, chain or chance. Int J Mol Sci 2017,18(12),1-28","journal-title":"Int J Mol Sci"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000510508","volume":"76","author":"Soliman S.","year":"2020","unstructured":"Soliman S.; Faris M.E.; Ratemi Z.; Halwani R.; Switching host metabolism as an approach to dampen SARS-CoV-2 infection. Ann Nutr Metab 2020,76(5),297-303","journal-title":"Ann Nutr Metab"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13337-021-00703-5","volume":"32","author":"Gnoni M.","year":"2021","unstructured":"Gnoni M.; Beas R.; V&#xE1;squez-Garagatti R.; Is there any role of intermittent fasting in the prevention and improving clinical outcomes of COVID-19?: Intersection between inflammation, mTOR pathway, autophagy and calorie restriction. Virusdisease 2021,32(4),1-10","journal-title":"Virusdisease"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/cphy.c180005","volume":"8","author":"Mani K.","year":"2018","unstructured":"Mani K.; Javaheri A.; Diwan A.; Lysosomes mediate benefits of intermittent fasting in cardiometabolic disease: The janitor is the undercover boss. Compr Physiol 2018,8(4),1639-1667","journal-title":"Compr Physiol"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"E1952","DOI":"10.3390\/cells9091952","volume":"9","author":"Pehote G.","year":"2020","unstructured":"Pehote G.; Vij N.; Autophagy augmentation to alleviate immune response dysfunction, and resolve respiratory and COVID-19 exacerbations. Cells 2020,9(9),E1952","journal-title":"Cells"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/ana.21798","volume":"67","author":"Arumugam T.V.","year":"2010","unstructured":"Arumugam T.V.; Phillips T.M.; Cheng A.; Morrell C.H.; Mattson M.P.; Wan R.; Age and energy intake interact to modify cell stress pathways and stroke outcome. Ann Neurol 2010,67(1),41-52","journal-title":"Ann Neurol"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530322666220516115604","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/204829\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530322666220516115604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T09:59:58Z","timestamp":1680602398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/204829\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":187,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530322666220516115604","relation":{},"ISSN":["1871-5303"],"issn-type":[{"type":"print","value":"1871-5303"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-12-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}